Latest news with #BNPParibasExane
Yahoo
22-07-2025
- Business
- Yahoo
CooperCompanies (COO) Stock Trades Up, Here Is Why
What Happened? Shares of medical device company CooperCompanies (NASDAQ:COO) jumped 3.4% in the morning session after analysts at BNP Paribas Exane upgraded the stock. The firm raised its rating on CooperCompanies from "neutral" to "outperform" and increased its price target to $92 from $76. This new target suggests a potential upside of nearly 29% from the stock's previous closing price. An analyst upgrade from a notable financial institution can often boost investor confidence by signaling a positive outlook on the company's future performance. After the initial pop the shares cooled down to $72.78, up 2% from previous close. Is now the time to buy CooperCompanies? Access our full analysis report here, it's free. What Is The Market Telling Us CooperCompanies's shares are not very volatile and have only had 8 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. The biggest move we wrote about over the last year was about 2 months ago when the stock dropped 15% on the news that the company reported underwhelming first-quarter 2025 results (fiscal Q2), with sales exceeding expectations by a whisker while organic sales growth guidance for the full year was lowered. Management called out "softening in two of its growth markets, contact lenses and fertility." On a brighter note, COO raised its full-year revenue and EPS guidance, off the back of the modest beat. In addition, its organic revenue and EPS outperformed Wall Street's estimates during the quarter. Overall, this print had some key positives. Investors were likely hoping for more. CooperCompanies is down 19.7% since the beginning of the year, and at $72.78 per share, it is trading 34.6% below its 52-week high of $111.23 from September 2024. Investors who bought $1,000 worth of CooperCompanies's shares 5 years ago would now be looking at an investment worth $1,005. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
Yahoo
21-07-2025
- Automotive
- Yahoo
BNP Paribas Exane Initiates Coverage on Garrett Motion (GTX) Stock
Garrett Motion Inc. (NASDAQ:GTX) is one of the Best Performing EV Stocks So Far in 2025. BNP Paribas Exane initiated coverage on the company's stock with an 'Outperform' rating and a price objective of $14.00. The firm pointed to Garrett Motion Inc. (NASDAQ:GTX)'s robust profitability, FCF conversion, and a clear commitment to capital returns. The company's net sales for Q1 2025 came in at $878 million, with net income reaching $62 million. The company continued to return capital to shareholders via $30 million of common share repurchases and its first quarterly dividend amounting to $12 million. A close up of an engine piston with a commercial turbocharger attached. Garrett Motion Inc. (NASDAQ:GTX) strengthened its global leadership in turbocharging and won new business with established and new automakers, primarily in plug-in hybrid and range-extended electric platforms. Garrett Motion Inc. (NASDAQ:GTX) also joined the Russell 2000® Index after the market closed on June 27. The company has reached a milestone in the development of its E-Powertrain high-speed technologies and secured the first series production award from Hyundai, a leading axle supplier, to integrate Garrett's high-speed E-motor and inverter technology into their axle and transmission platforms for the heavy-duty commercial vehicles, with production aimed for 2027. Garrett Motion Inc. (NASDAQ:GTX)'s growing suite of zero-emission products revolutionizes sustainable mobility by providing advanced, efficient, and high-performing solutions for EV propulsion and thermal management. McIntyre Partnerships, an investment management company, released its Q4 2024 investor letter. Here is what the fund said: 'Garrett Motion Inc. (NASDAQ:GTX) is a leading manufacturer in the moat-rich turbocharger (TB) market, with a global end-market and industry-leading margins. As TBs are not used in battery electric vehicles (BEVs), the market has concerns about GTX's terminal value, which is suppressing its valuation. GTX trades ~5x my 2025 levered FCF with leverage at 2x EBITDA. Beyond its core business in TBs, GTX has a separate BEV growth story that is currently pre-revenue with high upfront costs, depressing GTX's reported run-rate FCF. As a result, I believe GTX is even cheaper on owners' earnings than the headline numbers suggest. Beyond its BEV investments, GTX has been using its FCF to buy back significant amounts of stock. Since 2022, GTX has retired almost one-third of its shares outstanding. If either BEV penetration is less bad than feared or GTX has success in its BEV investments, I believe GTX shares are significantly undervalued. While we acknowledge the potential of GTX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
03-07-2025
- Business
- Yahoo
Meta upgraded, PNC Financial downgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The 5 Upgrades: Needham upgraded Meta Platforms (META) to Hold from Underperform with no price target. Channel checks are driving upside to the firm's estimates, but the firm remains on the sidelines with a Hold because the firm believes Meta's strategy diffusion "wastes capital and adds risks" and the company's margins and free cash flow are under structural downward pressure. BNP Paribas Exane upgraded FedEx (FDX) to Outperform from Underperform with a price target of $270, up from $230. While the U.S. domestic parcel market remains competitive and Amazon (AMZN) continues to present a major challenge to incumbents, FedEx is outperforming on both volume and yield growth on a relative basis and the shares are "arguably oversold," the firm tells investors. BNP Paribas Exane upgraded UPS (UPS) to Neutral from Underperform with a $100 price target. With consensus trending downwards, BNP's outlook is now "better matched by the Street" and volume headwinds appear to be priced in, the firm tells investors. Wolfe Research upgraded Huntington Bancshares (HBAN) to Outperform from Peer Perform with a $21 price target. The firm, which sees net interest income and net interest margin upside, expects shares will "generate meaningful alpha in the coming year," citing a combination of peer leading loan and deposit growth, ongoing productivity and efficiency improvements, benign credit, and capital returns. Morgan Stanley upgraded Valley National (VLY) to Overweight from Equal Weight with a price target of $11, up from $10. Valley has taken significant actions over the past year to lower its commercial real estate concentration, increase its reserve ratio, and build capital, but the balance sheet improvement and earnings growth story are not reflected in valuation, the firm tells investors. Top 5 Downgrades: Wolfe Research downgraded PNC Financial (PNC) to Peer Perform from Outperform and removed the firm's prior $185 price target. PNC screens as expensive compared to the Outperform-rated banks in the analyst's coverage that generate higher returns, the firm explains. Citizens JMP downgraded Two Harbors (TWO) to Market Perform from Outperform and removed the firm's prior $13.50 price target on the shares, citing uncertainty about the final level of damages yet to be determined in the ongoing lawsuit against its former external manager. Maxim downgraded NV5 Global (NVEE) to Hold from Buy with a $23 price target citing the pending takeover by Acuren for $23 per share. Raymond James downgraded Imperial Oil (IMO) to Market Perform from Outperform with a price target of C$107, up from C$105. With the Investor Day in the rearview mirror, it is challenging to see any near-term catalysts to drive continued outperformance, the firm tells investors in a research note. Berenberg downgraded Rio Tinto (RIO) to Hold from Buy with a price target of 4,700 GBp, down from 6,200 GBp. The firm is taking a more cautious view on iron ore and reduced estimates by about 5% over 2025-27, citing a lack of clear stimulus from China as "a key driver of this reduction." Top 5 Initiations: H.C. Wainwright initiated coverage of Telix Pharmaceuticals (TLX) with a Buy rating and $23 price target. TLX591, which is being studied in a global Phase 3 trial for metastatic castration-resistant prostate cancer, "appears differentiated" and TLX592 "further builds upon that," the firm argues. KeyBanc initiated coverage of Prairie Operating (PROP) with a Sector Weight rating and no price target. The firm sees "a chicken-or-egg conundrum" for Prairie on whether to enter into M&A now with a low trading multiple to re-rate the equity, or wait for the equity to re-rate before entering into more deals. BofA initiated coverage of Ralliant (RAL) with an Underperform rating and $48 price target. Ralliant has modestly underperformed peers over this cycle, with revenue declines below peers in Q1, the firm tells investors in a research note. Bullish on the name, Janney Montgomery Scott initiated coverage of Primoris (PRIM) with a Buy rating and $102 fair value estimate. Morgan Stanley analyst Sean Laaman assumed coverage of Schrodinger (SDGR) with an Equal Weight rating with a price target of $28, down from $31. Schrodinger has faced volatility due to a combination of macroeconomic factors, underperformance on initial clinical results and uncertainty on valuation and revenue drivers, the firm says.
Bloomberg
01-07-2025
- Business
- Bloomberg
Stock Movers: Sainsbury's, Zealand Pharma, Taylor Wimpey
On this episode of Stock Movers: - Sainsbury's has reported strong sales growth after the grocer used price-matching and promotions linked to its loyalty program to entice customers with food inflation accelerating across the UK. - Zealand Pharma shares rose as much as 5.1%, the most in six weeks, after BNP Paribas Exane analysts initiated coverage on the stock with an outperform recommendation, saying the 'attractive' risk-reward at current levels is 'difficult to ignore.' - UK house prices fell the most in more than two years in June, in a sign buyers are under pressure after an increase in transaction taxes in April, according to one of Britain's top mortgage lenders.
Business Insider
27-06-2025
- Business
- Business Insider
Alphabet downgraded to Neutral from Outperform at BNP Paribas Exane
BNP Paribas Exane analyst Stefan Slowinski downgraded Alphabet (GOOG) (GOOGL) to Neutral from Outperform with a $172 price target. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
